
Isoray ISR
Quarterly report 2025-Q3
added 11-10-2025
Isoray DIO Ratio 2011-2025 | ISR
Annual DIO Ratio Isoray
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 94.7 | 47.1 | 45.3 | 44.2 | 30.1 | 26.3 | 33.2 | 29.7 | 33.8 | 37.1 | 67.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.7 | 26.3 | 44.4 |
Quarterly DIO Ratio Isoray
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 66.4 | 62 | 81.5 | - | 103 | 73.9 | 69.3 | 60.8 | 60.6 | 28.6 | 60.6 | 50 | 51.6 | 49.4 | 47.7 | 43.6 | 43.6 | 44.2 | 43.3 | 39.3 | 43.1 | 39.6 | 41.9 | 41.4 | 37.4 | - | 32.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 28.6 | 52.6 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
457 | $ 24.51 | 0.49 % | $ 1.13 B | ||
|
Baxter International
BAX
|
109 | $ 19.45 | 1.57 % | $ 9.92 B | ||
|
Becton, Dickinson and Company
BDX
|
119 | $ 200.24 | -0.32 % | $ 57.6 B | ||
|
Harvard Bioscience
HBIO
|
202 | $ 0.72 | -3.0 % | $ 30.5 M | ||
|
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
152 | $ 147.83 | -0.41 % | $ 3.61 B | ||
|
iRhythm Technologies
IRTC
|
27.7 | $ 170.06 | 0.73 % | $ 5.31 B | ||
|
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | ||
|
Repro Med Systems
KRMD
|
153 | $ 5.73 | -0.87 % | $ 261 M | ||
|
LeMaitre Vascular
LMAT
|
338 | $ 84.3 | 0.35 % | $ 1.89 B | ||
|
Ekso Bionics Holdings
EKSO
|
209 | $ 4.64 | -0.64 % | $ 93.5 M | ||
|
Masimo Corporation
MASI
|
168 | $ 137.72 | -0.45 % | $ 7.34 B | ||
|
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | ||
|
Merit Medical Systems
MMSI
|
156 | $ 86.66 | -0.05 % | $ 5.05 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | ||
|
OraSure Technologies
OSUR
|
140 | $ 2.51 | 0.6 % | $ 187 M | ||
|
Alcon
ALC
|
126 | $ 79.51 | 0.9 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
222 | $ 41.55 | -1.96 % | $ 1.95 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
270 | $ 4.82 | 1.47 % | $ 26.6 K | ||
|
ResMed
RMD
|
141 | $ 252.92 | 0.26 % | $ 36.9 B | ||
|
AngioDynamics
ANGO
|
166 | $ 13.39 | 1.9 % | $ 547 M | ||
|
The Cooper Companies
COO
|
213 | $ 81.06 | -1.24 % | $ 16.1 B | ||
|
STAAR Surgical Company
STAA
|
164 | $ 23.98 | -0.62 % | $ 1.18 B | ||
|
STERIS plc
STE
|
75 | $ 253.49 | 0.68 % | $ 25 B | ||
|
Glaukos Corporation
GKOS
|
193 | $ 112.17 | 3.02 % | $ 5.43 B | ||
|
Haemonetics Corporation
HAE
|
204 | $ 80.33 | -3.78 % | $ 4.04 B | ||
|
InfuSystem Holdings
INFU
|
33.8 | $ 9.01 | -2.49 % | $ 186 M | ||
|
Utah Medical Products
UTMD
|
166 | $ 58.18 | 0.14 % | $ 211 M | ||
|
Intuitive Surgical
ISRG
|
182 | $ 557.08 | 2.72 % | $ 198 B | ||
|
Milestone Scientific
MLSS
|
528 | $ 0.36 | -6.38 % | $ 28.7 M | ||
|
Nephros
NEPH
|
176 | $ 4.82 | -3.98 % | $ 50.1 M | ||
|
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
80.2 | $ 22.05 | 0.36 % | $ 3.8 B | ||
|
Pro-Dex
PDEX
|
145 | $ 43.41 | 0.07 % | $ 143 M | ||
|
Pulse Biosciences
PLSE
|
89 | $ 14.45 | 1.44 % | $ 694 M | ||
|
Predictive Oncology
POAI
|
191 | - | - | $ 32.4 M | ||
|
Stereotaxis
STXS
|
250 | $ 2.38 | 0.63 % | $ 192 M | ||
|
DENTSPLY SIRONA
XRAY
|
118 | $ 11.45 | -1.04 % | $ 2.33 B | ||
|
Repligen Corporation
RGEN
|
227 | $ 159.03 | 1.04 % | $ 8.86 M | ||
|
Retractable Technologies
RVP
|
197 | $ 0.83 | 0.17 % | $ 24.8 M | ||
|
Teleflex Incorporated
TFX
|
166 | $ 126.56 | -0.09 % | $ 5.93 B | ||
|
West Pharmaceutical Services
WST
|
78.2 | $ 269.2 | 0.62 % | $ 19.7 B |